Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in CRINETICS PHARMACEUTICALS IN
BNP PARIBAS FINANCIAL MARKETS holds 27,533 shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $1.3M as of 2025-Q4. The position was increased (++14.9% shares). CRNX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.3M
Current Shares
27,533
Total Value Change
+$881,149
Total Shares Change
+18,591
Other major holders of CRNX: FMR LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 27,533 |
+14.9% |
| $1.3M |
| 0.0% |
| $47.39 |
29 |
| 2025-Q3 | Increased | 23,967 | +52.1% | $998,226 | 0.0% | $43.51 | 35 |
| 2025-Q2 | Increased | 15,755 | +50.5% | $453,114 | 0.0% | $29.96 | 33 |
| 2025-Q1 | Decreased | 10,468 | -31.4% | $351,097 | 0.0% | $34.73 | 0 |
| 2024-Q4 | Decreased | 15,259 | -27.1% | $780,193 | 0.0% | $50.67 | 0 |
| 2024-Q3 | Increased | 20,942 | +134.2% | $1.1M | 0.0% | $50.75 | 41 |
| 2024-Q2 | Decreased | 8,942 | -80.5% | $400,512 | 0.0% | $44.79 | 0 |